AAD's Dialogues in Dermatology

212 Jaksot

1. Practice Management Series: Reporting Mohs Surgery with a Simple Repair

   Julkaistiin: 24.5.2022
2. Bonus: Diagnosing Basal Cell Carcinoma - What's Next (Sponsored by Genentech)

   Julkaistiin: 13.5.2022
3. Bonus: Recap of Patient Safety and Quality Symposium

   Julkaistiin: 13.5.2022
4. Practice Management Series: Social Media in Dermatology

   Julkaistiin: 10.5.2022
5. Guidelines Series: Psoriasis Phototherapy Guidelines and Care Improvement Strategies

   Julkaistiin: 9.5.2022
6. Bonus: Physician Mental Health Awareness

   Julkaistiin: 5.5.2022
7. Dialogues in Dermatology: JAK Inhibitors

   Julkaistiin: 2.5.2022
8. May JAAD: Comorbidity screening in Hidradenitis Suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

   Julkaistiin: 2.5.2022
9. Bonus: Nonsurgical Treatment of Basal Cell Carcinoma (Sponsored by Genentech)

   Julkaistiin: 22.4.2022
10. Practice Management Series: Teledermatology Post COVID-19

    Julkaistiin: 19.4.2022
11. Bonus: AAD 2022 Election: Vice President-Elect Interview (Dr. Cyndi Yag-Howard)

    Julkaistiin: 11.4.2022
12. Bonus: AAD 2022 Election: President-Elect Interview (Dr. Seemal Desai)

    Julkaistiin: 11.4.2022
13. March JAAD: Diagnosing muscle disease in a cohort of classic dermatomyositis patients see at a rheumatologic dermatology outpatient clinic

    Julkaistiin: 25.3.2022
14. Practice Management Series: Coding and Reporting for Immunohistochemistry and Staining in Dermatology

    Julkaistiin: 11.3.2022
15. Practice Management Series: Top Administrative Burdens in Dermatology and How to Relieve Them

    Julkaistiin: 11.3.2022
16. Bonus: AAD 2022 Election: President-Elect Candidate Interview (Dr. Robert T. Brodell)

    Julkaistiin: 2.3.2022
17. Bonus: AAD 2022 Election: President-Elect Candidate Interview (Dr. Seemal R. Desai)

    Julkaistiin: 2.3.2022
18. Bonus: DataDerm - Synergistic Access to Data (Part II: Current Initiatives and Future Directions)

    Julkaistiin: 18.2.2022
19. February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

    Julkaistiin: 7.2.2022
20. January JAAD: Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6-months: a prospective analysis in the Corrona Psoriasis Registry

    Julkaistiin: 7.2.2022